Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

Etoricoxib

Catalog No. T1574Cas No. 202409-33-4
Alias Tauxib, Nucoxia, MK-663, L-791456, Desvenlafaxine, Arcoxia

Etoricoxib (MK-663) is a synthetic, nonsteroidal anti-inflammatory drug (NSAID) with antipyretic, analgesic, and potential antineoplastic properties. Etoricoxib specifically binds to and inhibits the enzyme cyclooxygenase-2 (COX-2), resulting in inhibition of the conversion of arachidonic acid into prostaglandins. Inhibition of COX-2 may induce apoptosis and inhibit tumor cell proliferation and angiogenesis.

Etoricoxib

Etoricoxib

Purity: 99.87%
Catalog No. T1574Alias Tauxib, Nucoxia, MK-663, L-791456, Desvenlafaxine, ArcoxiaCas No. 202409-33-4
Etoricoxib (MK-663) is a synthetic, nonsteroidal anti-inflammatory drug (NSAID) with antipyretic, analgesic, and potential antineoplastic properties. Etoricoxib specifically binds to and inhibits the enzyme cyclooxygenase-2 (COX-2), resulting in inhibition of the conversion of arachidonic acid into prostaglandins. Inhibition of COX-2 may induce apoptosis and inhibit tumor cell proliferation and angiogenesis.
Pack SizePriceAvailabilityQuantity
10 mg$30In Stock
25 mg$43In Stock
50 mg$61In Stock
100 mg$94In Stock
500 mg$263In Stock
1 mL x 10 mM (in DMSO)$30In Stock
Bulk & Custom
Add to Cart
Questions
View More

Related Compound Libraries of "Etoricoxib"

Select Batch
Purity:99.87%
Contact us for more batch information
Resource Download
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.

Product Introduction

Bioactivity
Description
Etoricoxib (MK-663) is a synthetic, nonsteroidal anti-inflammatory drug (NSAID) with antipyretic, analgesic, and potential antineoplastic properties. Etoricoxib specifically binds to and inhibits the enzyme cyclooxygenase-2 (COX-2), resulting in inhibition of the conversion of arachidonic acid into prostaglandins. Inhibition of COX-2 may induce apoptosis and inhibit tumor cell proliferation and angiogenesis.
Targets&IC50
COX-2:1.1 μM COX-1
In vivo
The preferential cyclooxygenase-2 inhibitor etoricoxib significantly reduces the anticonvulsant action of phenytoin and significantly increases the beneficial action of diazepam against maximal electroshock and pentylenetetrazole-induced convulsions in a mouse model[1]. Etoricoxib has the potential to act as an anti-apoptotic and anti- proliferative agent in the colon[2].
Cell Research
Human colon carcinoma cell line HCT-116 are treated with various coxibs for 2 h. Subsequently, the cells are harvested and the sphingolipids isolated and determined by LC-MS/MS. (Only for Reference)
AliasTauxib, Nucoxia, MK-663, L-791456, Desvenlafaxine, Arcoxia
Chemical Properties
Molecular Weight358.84
FormulaC18H15ClN2O2S
Cas No.202409-33-4
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
Solubility Information
Ethanol: 43 mg/mL (119.8 mM)
DMSO: 50 mg/mL (139.34 mM)
H2O: < 1 mg/mL (insoluble or slightly soluble)
Solution Preparation Table
Ethanol/DMSO
1mg5mg10mg50mg
1 mM2.7868 mL13.9338 mL27.8676 mL139.3379 mL
5 mM0.5574 mL2.7868 mL5.5735 mL27.8676 mL
10 mM0.2787 mL1.3934 mL2.7868 mL13.9338 mL
20 mM0.1393 mL0.6967 mL1.3934 mL6.9669 mL
50 mM0.0557 mL0.2787 mL0.5574 mL2.7868 mL
100 mM0.0279 mL0.1393 mL0.2787 mL1.3934 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
TargetMol | Animal experimentsFor example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。
Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSOTargetMol | reagent (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μL DMSOTargetMol | reagent main solution, add 300 μLPEG300TargetMol | reagent mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2OTargetMol | reagent mix well and clarify
For Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
%Tween 80
%ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy Etoricoxib | purchase Etoricoxib | Etoricoxib cost | order Etoricoxib | Etoricoxib chemical structure | Etoricoxib in vivo | Etoricoxib formula | Etoricoxib molecular weight